Target intelligence / Profile preview

Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA)

Target
SGTA
Molecular classification
Co-chaperone, Other
01

Overview

Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) is a ubiquitously expressed co-chaperone that plays a critical role in cellular proteostasis and protein quality control. It consists of three distinct domains: an N-terminal dimerization domain, a central tetratricopeptide repeat (TPR) domain, and a C-terminal glutamine-rich region. SGTA interacts with molecular chaperones like HSP70 and HSP90, as well as the BAG6 complex, to capture misfolded or mislocalized hydrophobic proteins in the cytosol and direct them toward either refolding or proteasomal degradation. Additionally, SGTA acts as a key regulator of steroid hormone receptors, particularly the androgen receptor (AR), by binding to its hinge region and retaining it in the cytoplasm, thereby suppressing androgen signaling.

Due to its diverse roles, SGTA is implicated in several pathologies, including hormone-dependent cancers (such as prostate and breast cancer), polycystic ovary syndrome (PCOS), viral infections (by interacting with viral proteins like HIV-1 Vpu and SARS-CoV accessory protein 7a), and neurodegenerative diseases associated with protein aggregation. In therapeutic development, SGTA is considered an attractive target for small-molecule inhibitors and RNA interference therapies. For instance, the natural product derivative methyl gerfelin has been shown to bind SGTA. However, because SGTA is ubiquitously expressed and interacts with numerous cellular proteins, therapeutic targeting presents significant safety challenges, including potential systemic toxicity and unintended alterations in steroid receptor signaling.

Other names
Alpha-SGTSGThSGTVpu-binding proteinUBPSmall glutamine-rich tetratricopeptide repeat co-chaperone alphaSmall glutamine-rich tetratricopeptide repeat-containing protein A
02

Mechanism of action

Inhibition of SGTA co-chaperone activity and disruption of its protein-protein interactions with chaperones or client proteins

03

Biological functions

Protein foldingProtein quality controlApoptosisCell cycleSignal transductionViral assembly and releaseOther
04

Disease associations

CancerInfectionNeurodegenerative diseaseOther
05

Safety considerations

Ubiquitous expression leading to potential off-target toxicityDisruption of essential protein quality control pathwaysPotential enhancement of androgen receptor signaling if cytoplasmic retention is blockedMitotic arrest and cell death in healthy tissues
06

Interacting drugs

07

Biomarkers

SGTA expression levelAndrogen receptor expression levelAR:SGTA ratio

Beyond the preview

Go deeper on Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call